SCHEMBL2471330

SCHEMBL2471330

Oc1ccc(OCCOCCOc2ccc(O)cc2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 2/20 0.67
LTA4H P09960 4/20 0.57
NR5A1 Q13285 1/20 0.57
DRD4 P21917 2/20 0.50
LMNA P02545 1/20 0.50
CYP1A2 P05177 1/20 0.50
PTGS1 P23219 1/20 0.50
SLC6A2 P23975 1/20 0.50
CYP2C19 P33261 1/20 0.50
PTGS2 P35354 1/20 0.50
SLC6A3 Q01959 1/20 0.50
HIF1A Q16665 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
DRD2 P14416 1/20 0.50
DRD3 P35462 1/20 0.50
KDM4E B2RXH2 1/20 0.48
MAPK1 P28482 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19284359 1.00 APP (0.67) APPLTA4HNR5A1DRD4LMNA
SCHEMBL6860317 1.00 APP (0.67) APPLTA4HNR5A1DRD4LMNA
SCHEMBL24799496 0.93 APP (0.61) APPLTA4HNR5A1DRD4LMNA
SCHEMBL4354892 0.93 APP (0.61) APPLTA4HNR5A1DRD4LMNA
SCHEMBL226548 0.92 LTA4H (0.64) APPLTA4HNR5A1DRD4LMNA
SCHEMBL1412776 0.91 APP (0.64) APPLTA4HNR5A1LMNAMAPK1
SCHEMBL1412728 0.91 APP (0.64) APPLTA4HNR5A1LMNAMAPK1
SCHEMBL1815639 0.91 APP (0.64) APPLTA4HNR5A1LMNAMAPK1
SCHEMBL24799927 0.91 DRD4 (0.62) APPLTA4HNR5A1DRD4LMNA
SCHEMBL1412773 0.91 APP (0.64) APPLTA4HNR5A1LMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230133211-A1 PHOTOCHROMIC CYCLIC COMPOUND AND CURABLE COMPOSITION CONTAINING THE PHOTOCHROMIC CYCLIC COMPOUND TOKUYAMA CORPORATION (JP) 2023-05-04 US disclosed
US-20230133211-A1 PHOTOCHROMIC CYCLIC COMPOUND AND CURABLE COMPOSITION CONTAINING THE PHOTOCHROMIC CYCLIC COMPOUND TOKUYAMA CORPORATION (JP) 2023-05-04 US disclosed
EP-2461413-A1 Polymer electrolyte Sumitomo Chemical Company Limited (JP) 2012-06-06 EP disclosed
EP-2461412-A1 Polymer electrolyte Sumitomo Chemical Company Limited (JP) 2012-06-06 EP disclosed
EP-1348716-B1 Aromatic polymer, method for producing the same and uses thereof SUMITOMO CHEMICAL CO (JP) 2011-10-12 EP disclosed
US-7396608-B2 Polymer electrolyte and method for producing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2008-07-08 US disclosed
EP-1890355-A2 Polymer electrolyte and method for producing the same Sumitomo Chemical Company, Limited (JP) 2008-02-20 EP disclosed
US-7285616-B2 Aromatic polymer, method for producing the same and uses thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-10-23 US disclosed
US-20040220354-A1 Polymer electrolyte and method for producing the same SUMITOMO CHEMICAL COMPANY, LIMITED 2004-11-04 US disclosed
US-6761989-B2 FUEL CELL SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-07-13 US disclosed
EP-1348716-A1 Aromatic polymer, method for producing the same and uses thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-10-01 EP disclosed
US-20030180596-A1 Aromatic polymer, method for producing the same and uses thereof SUMITOMO CHEMICAL COMPANY, LIMITED 2003-09-25 US disclosed
US-20010041279-A1 Polymer electrolyte and method for producing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2001-11-15 US disclosed
EP-1113517-A2 Polymer electrolyte and method for producing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2001-07-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230133211-A1 PHOTOCHROMIC CYCLIC COMPOUND AND CURABLE COMPOSITION CONTAINING THE PHOTOCHROMIC CYCLIC COMPOUND CRY1, CCNL2, CCNT1 APP 2032/4885LTA4H 1429/4885NR5A1 3479/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.